Page last updated: 2024-10-31

metoclopramide and Multiple Myeloma

metoclopramide has been researched along with Multiple Myeloma in 1 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cersosimo, RJ1
Brophy, MT1

Other Studies

1 other study available for metoclopramide and Multiple Myeloma

ArticleYear
Hiccups with high dose dexamethasone administration: a case report.
    Cancer, 1998, Jan-15, Volume: 82, Issue:2

    Topics: Antineoplastic Agents, Hormonal; Dexamethasone; Dopamine Antagonists; Follow-Up Studies; Glucocortic

1998